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a b s t r a c t 
Serum, urine and tissue from a rat model of chronic kid- 
ney disease (CKD) were analysed using nuclear magnetic res- 
onance (NMR) spectroscopy-based metabolomics methods, 
and compared with samples from sham operated rats. Both 
urine and serum were sampled at multiple timepoints, and 
the results have been reported elsewhere ( https://doi.org/10. 
1007/s11306- 019- 1569- 3 [1] ). The data could be useful to re- 
searchers working with human CKD or rat models of the 
disease. In addition, several different types of NMR spectra 
were recorded, including 1D NOESY, CPMG, and 2D J-resolved 
spectra, and the data could be useful for method compari- 
son and algorithm development, both in terms of NMR spec- 
troscopy and multivariate analysis. 
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pecifications Table 
Subject Biochemistry 
Specific subject area NMR-based metabolomics in an animal model of chronic kidney disease 
Type of data 1 H NMR spectra 
How data were acquired Bruker 600 MHz Avance DRX-600 NMR spectrometer equipped with a 
TXI probe 
Data format Raw and processed 1 H NMR spectra (in Bruker format) 
Parameters for data collection The 5/6 nephrectomy rat model of chronic kidney disease (CKD) was 
compared to sham operation, by analysing NMR spectra of urine, serum 
and tissue samples. 
Description of data collection Urine and serum were collected at multiple timepoints after 5/6 
nephrectomy or sham operation. Tissue samples (kidney, lung, heart, 
spleen and liver) were collected when animals were euthanised. Urine 
and serum were mixed with phosphate buffer, and tissue samples were 
extracted and reconstituted in phosphate buffer, before 1 H NMR spectra 
were acquired. 
Data source location Aalborg University, Aalborg, Denmark 
Data accessibility MetaboLights database ( www.ebi.ac.uk/metabolights ) accession number 
MTBLS2052 ( www.ebi.ac.uk/metabolights/MTBLS2052 ) 
Related research article M.A. Hanifa, M. Skott, R.G. Maltesen, B.S. Rasmussen, S. Nielsen, J. 
Frøkiær, T. Ring, R. Wimmer. Tissue, urine and blood metabolite 
signatures of chronic kidney disease in the 5/6 nephrectomy rat model. 
Metabolomics, 15 (2019) 112. https://doi.org/10.1007/s11306- 019- 1569- 3 . 
alue of the Data 
• The dataset provides a unique combination of tissue, urine and serum NMR spectra from the
rat CKD model, as well as a control group for comparison. 
• Researchers who are interested in CKD, as well as those interested in metabolomics in gen-
eral, can benefit from this dataset. 
• This dataset can be used as a validation group for other rat CKD studies, or as part of a
feasibility study for new rat experiments. The development of the urine metabolomic profile
over time could be of interest in planning human experiments. 
• Comparison of tissue, urine and serum spectra, and comparison of different types of NMR
spectra, may be interesting. 
. Data Description 
The data consists of raw and processed proton nuclear magnetic resonance ( 1 H NMR) spectra,
hich are in standard Bruker format. NMR spectra were acquired on samples collected from rats
fter 5/6 nephrectomy or sham operation [1] . There were a total of 147 urine samples, 53 serum
amples, and 130 tissue samples, and for each collected sample multiple NMR spectra were
ecorded using different pulse sequences: 1D nuclear Overhauser effect spectroscopy (NOESY),
arr-Purcell-Meiboom-Gill (CPMG), 2D J-resolved (JRES) including a skyline projection (pJRES),
nd a quantitative NOESY spectrum using a long relaxation delay (qNOESY). For urine samples
ll four spectra were recorded; no CPMG spectra were recorded for tissue extracts; and only
PMG and JRES spectra were recorded for serum samples. 
M.A. Hanifa, M. Skott and R.G. Maltesen et al. / Data in Brief 33 (2020) 106567 3 
Table 1 
Naming convention of NMR spectra. 
Label digits Represents Possible values 
First and second Tissue type Urine (10), serum (21), remnant kidney (50), left sham 
kidney (51), right sham kidney (52), lung (60), heart 
(61), spleen (62), liver (63) 
Third and fourth Rat number 01–30 (no data for rats 01, 06, 16, 19, 22 or 23) 
Fifth and sixth Week number 00–06 (illustrated in Fig. 1 ) 
Seventh and eighth Spectral type NOESY (01), CPMG (02), JRES (03), qNOESY (04) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Each file has an eight-digit label, read as four pairs of numbers. The first pair represent tissue
type, the second pair represent rat number, the third pair represent week number, whilst the
fourth pair represent spectral type. Details of the scheme are presented in Table 1 . Rats 1, 6, 16,
19, 22, and 23 died before the end of the experiment, mostly during or immediately after the
surgical procedures, and therefore no data is available for these rats. 
2. Experimental Design, Materials and Methods 
2.1. Animal models and sample collection 
Following approval from the Danish Ministry of Justice, 30 male Wistar rats (Taconic, Ejby,
Denmark) were randomized, 17 to the 5/6 nephrectomy group and 13 to the sham operation
group. More rats were randomised to the 5/6 nephrectomy group because the procedure was
more extensive, and more rats were expected to die during surgery. The 5/6 nephrectomy pro-
cedure was carried out in two stages, initial (week -1) removal of approximately 2/3 of the left
kidney together with insertion of a suprapubic catheter, followed one week later (week 0) by re-
moval of the entire right kidney [2] . Sham rats also underwent a surgical procedure, however, no
kidney tissue was removed. All surgical procedures were carried out under 2% isoflurane anaes-
thesia (Abbott Scandinavia, Solna, Sweden), and buprenorphine (Reckitt Benckiser, Slough, UK)
was administered subcutaneously and via drinking water for pain relief. After surgery, rats had
free access to tap water and standard rat chow (Altromin, Lage, Germany). 
One week after the second operation and weekly thereafter (weeks 1–6 inclusive, see Fig. 1 ),
a custom-built restraining cage was used to collect urine via a silicone tube connected from the
suprapubic catheter into an Eppendorf tube suspended in a mixture of ice and water. During
urine collection, rats were awake and had free access to water, whilst blood and tissue sam-
ples were collected whilst the rats were anesthetised. The tail vein was used to collect serum in
weeks 0 and 3, although this proved difficult, and many serum samples are missing from these
timepoints. Cardiac puncture was used to collect blood and obtain serum at the end of the ex-
periment (week 6), and tissue was also collected at this point. Serum and urine were centrifuged
and aliquoted, and all samples were frozen in liquid nitrogen and stored at -80 °C until analysis. 
2.2. Sample preparation and NMR analysis 
Metabolomics protocols published by Beckonert et al. and Dona et al. were followed [3 , 4] .
Urine and serum samples were left to thaw at 4 °C, vortexed briefly, and then centrifuged to
remove precipitate (140 0 0 x g and 4 °C for 5 min). Urine was mixed in a 9:1 ratio with buffer
(1.5M KH 2 PO 4 , 2 mM NaN 3 and 0.1% TSP dissolved in 99% D 2 O, pH 
∗ 7.4), whilst serum was
mixed 1:1 with buffer (0.075M NaH 2 PO 4 , 0.04% NaN 3 and 0.08% TSP dissolved in 20% D 2 O, pH 
∗
7.4). Urine samples were re-centrifuged, because of precipitate formation after buffer addition,
before transferring to an NMR tube for analysis. 
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Fig. 1. Sample collection protocol illustrating the timing of surgery, urine collection, serum collection, and tissue collec- 
tion. 
Table 2 
Acquisition details for serum, urine and tissue spectra. 
1D NOESY 1D CPMG J-resolved 
Number of scans 128 
64 (qNOESY) 
128 4 (per increment) 
Data points (time domain) 65536 (urine + tissue) 65536 Direct dimension: 16384 
Indirect dimension: 42 
Spectral width 20 ppm (urine + tissue) 20 ppm Direct dimension: 12 ppm 
Indirect dimension: 54 Hz 
Acquisition time 2.73 s 2.73 s 1.17 s 
Receiver gain 90.5 (urine) 
203 (tissue) 
90.5 (serum + urine) 64 (serum + urine) 
203 (tissue) 
Relaxation delay 4 s 
27.3 s (qNOESY) 
4 s 4 s 
B1 field strength 22 Hz (urine) 
20 Hz (tissue) 
17 Hz (serum) 
22 Hz (urine) 
20 Hz (tissue) 
17 Hz (serum) 
22 Hz (urine) 
20 Hz (tissue) 
Spectral size 131,072 131,072 Direct dimension: 32768 
Indirect dimension: 64 
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b  Tissue samples were lyophilised and then homogenised with a Precellys homogenizer (Bertin
nstruments, Montigny-le-Bretonneux, France). Metabolites were extracted using an ice-cold
ethanol, chloroform and water (2:2:1.8) protocol [5 , 6] . The hydrophilic phase was transferred
o a clean vial, lyophilised, and then dissolved in 0.1 M imidazole-d 4 buffer (0.02% NaN 3 and 1
M TSP dissolved in 99% D 2 O, pH 
∗ 7.0). 
1 H NMR spectra were recorded on a 60 0 MHz Bruker DRX-60 0 equipped with a TXI probe
Bruker BioSpin, Rheinstetten, Germany), using the following pulse programs: noesygppr1d, cp-
gpr1d and jresgpprqf. Serum spectra were acquired at 310 K, whilst urine and tissue spectra
ere acquired at 298 K. Further acquisition details are listed in Table 2 . 
.3. Referencing and normalisation usage notes 
Urine and tissue spectra have been referenced to the TSP signal, whilst serum spectra have
een referenced to the α-H 1 -glucose duplet at 5.24 ppm, because TSP binds to blood proteins
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which can have an effect on the TSP integral and lineshape. No normalisation has been applied
to the NMR spectra, however different normalisation strategies can be attempted: urine spectra
can be normalised to the creatinine integral at approximately 3.05 ppm, or to total spectral
intensity, due to widely varying urine concentrations; serum spectra can be normalised to the
PULCON [7] signal at -2 ppm; and tissue spectra can be normalised to the TSP signal, followed
by normalisation to extracted tissue mass (details of which are included in the MetaboLights
sample table). 
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